Karyopharm Therapeutics (KPTI) Net Income towards Common Stockholders Growth (3y) (2015 - 2025)
Karyopharm Therapeutics (KPTI) Net Income towards Common Stockholders Growth (3y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-10.84% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
26.38% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
34.98% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Karyopharm Therapeutics |
95.31 Mn |
31.56 Mn |
32.74 Mn |
63.14% |
| Date | Value |
|---|
| Dec 31, 2025 |
63.14% |
| Sep 30, 2025 |
3.02% |
| Jun 30, 2025 |
8.77% |
| Mar 31, 2025 |
17.25% |
| Dec 31, 2024 |
-12.76% |
| Sep 30, 2024 |
14.78% |
| Jun 30, 2024 |
34.70% |
| Mar 31, 2024 |
13.34% |
| Dec 31, 2023 |
-33.18% |
| Sep 30, 2023 |
13.60% |
| Jun 30, 2023 |
11.09% |
| Mar 31, 2023 |
13.61% |
| Dec 31, 2022 |
7.50% |
| Sep 30, 2022 |
4.24% |
| Jun 30, 2022 |
-4.16% |
| Mar 31, 2022 |
14.47% |
| Dec 31, 2021 |
47.08% |
| Sep 30, 2021 |
-2.52% |
| Jun 30, 2021 |
-16.77% |
| Mar 31, 2021 |
-14.29% |
